There's a saying in the markets that there's always a bull market
somewhere. Along similar lines, it's almost always possible to find
areas of growth in otherwise stagnant med-tech markets. While the
overall performance of the orthopedic market has been pretty
uninspiring of late, the extremities sub-sectors (upper and lower
extremities) have been notable exceptions.
Growing share in lower extremities is not the only positive factor at work in pushing Wright Medical (NSDQ:WMGI)
to new highs. After years of pursuing what I believe to have been an
unrealistic business model and a scandal tied to the industry-wide
practice of improper payments to surgeons to use their implants, CEO Bob
Palmisano has the company on the right track again. Two years into his
tenure as CEO, there's still ground to cover in terms of margins, but
the company's sales strategy for recon, its growth in extremities, and
the assets acquired from BioMimetic Therapeutics make this a name to
watch in the sleepy ortho sector.
Please follow this link to read the full article:
http://www.massdevice.com/blogs/massdevice/smarter-strategic-moves-bode-well-wright-medical
No comments:
Post a Comment